Dalriada Drug Discovery

💡Check out our 26th issue of [Small Molecule Highlights] to discover 4 brand-new compounds from recent drug discovery journals. 🧪 These molecules target a diverse selection of targets, including EGFR, LMP2, SyK and the NLRP3 inflammasome. Enjoy! Explore the full article here➡️ https://lnkd.in/gCXBhM8K #drugdesign #drugdiscovery #drughunter #pharma #biotech #healthcare #medicine #pharmacology #smallmolecules

💡Check out our 25th issue of [Small Molecule Highlights] to discover 4 brand-new compounds from recent drug discovery journals. 🧪These molecules target G9a/GLP, SLC13A5, PI3Kd and PRMT5. Enjoy! Explore the full article here➡️ https://lnkd.in/g-w8h-Ai #drugdesign #drugdiscovery #drughunter #pharma #biotech #healthcare #medicine #pharmacology #smallmolecules

We’re thrilled to announce another milestone for Dalriada Drug Discovery—reaching 10,000 followers on LinkedIn! 🎉✨   🔬 Pioneering Breakthroughs: Our journey has been defined by innovation and a relentless pursuit of scientific excellence. From the inception of Dalriada, our mission has been crystal clear: to be an ultimate partner in drug discovery and bring life-changing therapies to those in need. Each breakthrough, every discovery, and all our efforts are dedicated to this noble cause.   🤝 Community of Changemakers: We owe this achievement to our incredible community—passionate scientists, dedicated researchers, visionary leaders, and supporters who have believed in our mission from day one. Your engagement, feedback, and enthusiasm have been the driving force behind our success. Together, we are not just building a company, but a movement towards a healthier and brighter future.   🌟 Celebrating Progress: As we celebrate this milestone, we also reflect on the significant progress we’ve made. From identifying promising drug candidates to advancing them through rigorous preclinical and clinical trials, every step forward brings us closer to our goal. We're proud of what we've accomplished so far, but we're even more excited about the journey ahead.   🌍 Global Impact: Our reach extends far beyond our laboratory walls. Through collaborations with academic institutions, pharmaceutical partners, and healthcare organizations worldwide, we're amplifying our impact and accelerating the pace of discovery. Together, we're shaping the future of medicine and making a difference in the lives of millions.   🔍 What's Next?: Our journey is far from over. With your continued support, we're poised to achieve even greater milestones. We're doubling down on our commitment to innovation, pushing the boundaries of science, and unlocking new possibilities in drug discovery. Together, we will shape a healthier, happier world for generations to come. Thank you to each and every one of our 10,000 followers for being part of this incredible journey. Your support fuels our passion and drives us forward. Here's to the next chapter of discovery, collaboration, and impact. Together, we're unstoppable.   #DalriadaDrugDiscovery #DrugDiscovery #Innovation #Science #Milestone #Community #Impact #Healthcare #FutureOfMedicine

🌟 Celebrating World Laboratory Day 2024 with Dalriada Drug Discovery! 🌟 On this special occasion, we at Dalriada Drug Discovery are proud to commemorate World Laboratory Day, honoring the remarkable contributions of laboratories worldwide in advancing scientific knowledge and innovation. At Dalriada, our dedicated team of researchers, scientists, and experts work tirelessly in our state-of-the-art laboratories, driven by a passion for discovery and a commitment to improving global health. Through cutting-edge research and groundbreaking discoveries, we strive to develop novel therapeutics that address unmet medical needs and transform lives. Today, as we reflect on the significance of laboratories in driving progress and fostering collaboration, we reaffirm our commitment to excellence, integrity, and scientific rigor. Together, we continue to push the boundaries of science, unlocking new possibilities and paving the way for a healthier, more resilient future. Join us in celebrating the spirit of innovation and discovery on this World Laboratory Day. Together, let's salute the incredible work of laboratories worldwide and their invaluable contributions to society. #WorldLaboratoryDay #Innovation #Science #DrugDiscovery #Healthcare #DalriadaDrugDiscovery

💡If you haven't already, be sure to check out our [Small Molecule Highlights] issue #24. Discover 5 brand-new compounds from recent drug discovery journals. 🧪 These molecules target a diverse selection of targets, including RXFP1, BRD4, eIF2B, and PKa. Explore the full article here➡️ https://lnkd.in/g5tqn6BZ #drugdesign #drugdiscovery #drughunter #pharma #biotech #healthcare #medicine #pharmacology #smallmolecules

Tom Coulter, our Head of Drug Discovery Programs & Partnerships will be representing Dalriada at the SWISS Biotech Day 2024!  This event brings together numerous key players in the biotech industry and provides a platform for networking, engaging in scientific discussions and exploring recent advancements in R&D.  We are looking forward to connecting with industry leaders, expanding our network and exploring potential partnership opportunities within the drug development community.  Learn more about Dalriada and our Drug Discovery services here: https://dalriadatx.com/ #DalriadaDrugDiscovery #SWISSBiotechDay2024 #DiscoveryPartner #Collaboration #Networking  #LifeScience #Biotech #Pharma  

Our CEO will be representing Dalriada Drug Discovery at the upcoming Bloom Burton & Co. Healthcare Investor Conference on April 16-17!   This event serves as a dynamic platform for industry leaders to converge, exchange ideas, and drive innovation in healthcare. We are committed to advancing groundbreaking solutions and fostering strategic partnerships that shape the future of healthcare.   Stay tuned for live updates and insights from the conference as we continue to pave the way for transformative change in the healthcare landscape!   #BloomBurtonConference #HealthcareInnovation #Leadership #Networking #InvestorConference

We are excited to launch our series on Protein Sciences+ at Dalriada Drug Discovery!  At Dalriada Drug Discovery we care as much as you do about obtaining highest quality and truly fit-for-purpose protein to enable discovery programs from Hit ID to PDC. Why? While the therapeutic modalities are undergoing rapid innovation (TPD, Covalency, XTAC), protein assays and proteins screens remain at the heart of target-oriented drug discovery.  We ourselves rely on our own protein production department to successfully enable the downstream applications in crystallography, ITC, SPR, covalent MS screens, DSLS, DSF, MST, BLI, and a wide array of biochemical assays. At Dalriada, we don’t just care about delivery of required protein, we care about the protein delivered to be truly fit-for-purpose to enable a program to successful PDC nomination.   Our North American team, with deep roots from Structural Genomics Consortium, has over the years delivered dozens of recombinant protein and protein complexes with successful downstream applications and breaking published and previously obtained records in yield and quality.  We are excited to announce that we have made significant investments recently in expanding our capacity across all protein production platforms including bacterial, insect, mammalian, and protein membranes, which brings us again to the new heights of supporting stand-alone protein production programs as well as integrated discovery programs.  If you have an upcoming need in protein sciences/assays/screening, don’t hesitate to reach out to us here https://lnkd.in/g23nGskJ.  Look forward to sharing more in our next post on Protein Sciences+ Dalriada Drug Discovery #ProteinSciences #DrugDiscovery #ProteinProduction #HITID

💡Check out our 24th issue of [Small Molecule Highlights] to discover 5 brand-new compounds from recent drug discovery journals. 🧪 These molecules target a diverse selection of targets, including RXFP1, BRD4, eIF2B, and PKa. Enjoy! Explore the full article here➡️ https://lnkd.in/g5tqn6BZ #drugdesign #drugdiscovery #drughunter #pharma #biotech #healthcare #medicine #pharmacology #smallmolecules

The Swiss Biotech Day, the leading biotech conference in Switzerland, kicks off in two weeks and we are proud to bring together ten Canadian companies ready to forge meaningful partnerships with the Swiss life science community. Get in touch with us through the partnering or at the booth in the Global Village to start a strong and lasting partnership: Dalriada Drug Discovery Eyam Vaccines and Immunotherapeutics   Future Fields   Hermay Labs Corporation   Life360 Innovations   Myomar Molecular Nimble Science   PolyAnalytik Inc.   Precision NanoSystems Inc.   Q&C Services Stayed tuned as we highlight these companies in the next days.    Swiss Biotech Association Trade Commissioner Service | Service des délégués commerciaux Swiss Business Hub Canada